Company Pharmacolog i Uppsala AB (publ) Nasdaq Stockholm
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- | - |
04-24 | Perpetua Medical AB Appoints Camilla Lonn as CFO | CI |
04-23 | Pharmacolog i Uppsala AB will Change its Ticker to PERP B from PHLOG B | CI |
Business Summary
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drugs Quality Assurance Solutions
100.0
%
| 10 | 100.0 % | 10 | 100.0 % | -1.76% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 10 | 100.0 % | 10 | 100.0 % | -1.76% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hans Erik Dahlin
FOU | Founder | 79 | 14/01/07 |
LiseLotte Söder
DFI | Director of Finance/CFO | 60 | 31/12/20 |
Chairman | 76 | 31/12/16 | |
Asal Attabipour
PRN | Corporate Officer/Principal | 41 | 31/12/21 |
Susanne Grimsby
LAW | General Counsel | 63 | 31/12/17 |
Torbjörn Norberg
PRN | Corporate Officer/Principal | 59 | 31/12/17 |
Åsa Stroofe
SAM | Sales & Marketing | 56 | 31/05/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 76 | 31/12/16 | |
Hans Erik Dahlin
FOU | Founder | 79 | 14/01/07 |
Ragnar Linder
BRD | Director/Board Member | 71 | 31/12/18 |
Director/Board Member | 47 | 29/06/23 | |
Anders Hedlund
CEO | Chief Executive Officer | - | 29/06/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 108,520,716 | 74,802,036 ( 68.93 %) | 0 | 68.93 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-27.52% | 16.33B | |
-40.04% | 2.96B | |
+15.16% | 1.82B | |
-6.86% | 1.55B | |
+38.67% | 1.41B | |
-15.36% | 976M | |
-26.08% | 846M | |
+3.53% | 811M | |
-24.63% | 631M |
- Stock Market
- Equities
- PERP B Stock
- Stock
- Company Pharmacolog i Uppsala AB (publ)